Objective, Passive Assessment of LRRK2 Carriers

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

April 27, 2022

Primary Completion Date

May 7, 2024

Study Completion Date

May 7, 2024

Conditions
Parkinson Disease
Interventions
DEVICE

Emerald device

The Emerald device is a wireless sensor that can track the motion, breathing, and sleep of participants without touching or requiring any interaction with the participants, allowing them to go about their normal lives. The Emerald device operates by transmitting and receiving low power radio signals that reflect off of the participant and return back to the device. The power of these signals is 1,000 times lower than what a typical Wi-Fi device transmits. The ability of the device to monitor gait, breathing, sleep, and other metrics has been validated and documented. Studies of the Emerald device in individuals with Parkinson's disease, Alzheimer's disease, and rare diseases have demonstrated the feasibility of monitoring at home and the ability to characterize gait, breathing, and sleep in these populations specifically. In this study, the Emerald device will be used to characterize the mobility, breathing and sleep of the participant.

Trial Locations (1)

14620

University of Rochester, Rochester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Emerald Innovations

UNKNOWN

collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

lead

University of Rochester

OTHER

NCT05287620 - Objective, Passive Assessment of LRRK2 Carriers | Biotech Hunter | Biotech Hunter